LCIP
MRK icon

Life Cycle Investment Partners’s Merck MRK Stock Holding History

Life Cycle Investment Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.7M Buy
+371,133
New +$43.4M 0.22% 90

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Life Cycle Investment Partners's MRK Position: Q2 2026 in Review

Life Cycle Investment Partners opened a new position in Merck (MRK) in Q2 2026: 371,133 shares worth $47.7M. The stake represents 0.22% of the portfolio and ranks #90 among its holdings.

3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Life Cycle Investment Partners held 371,133 shares of Merck worth $47.7M as of Q2 2026.
  • Merck was a new Life Cycle Investment Partners position in Q2 2026.
  • Merck made up 0.22% of Life Cycle Investment Partners's portfolio in Q2 2026, its #90 holding.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Life Cycle Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.